Stay updated on Dara-VCd vs VTd, Maintenance with IXA Clinical Trial

Sign up to get notified when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    New related topics and resource links were added. They include Multiple myeloma and MedlinePlus Genetics in the related topics section.
    Difference
    0.1%
    Check dated 2026-09-14T20:02:46.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Removed the disease label 'Multiple myeloma' and the related topics section including 'MedlinePlus Genetics' from the study page. This reduces explicit condition context and linked informational resources for users reviewing the trial.
    Difference
    0.1%
    Check dated 2026-09-07T20:55:47.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 appears in the footer. Related topics now include 'Multiple myeloma' and 'MedlinePlus Genetics' to aid navigation.
    Difference
    0.2%
    Check dated 2026-08-31T18:10:31.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision tag (Revision: v3.6.5) was added and the older Revision: v3.6.4 reference was removed; related-topic entries such as Multiple myeloma and MedlinePlus Genetics were deleted.
    Difference
    0.2%
    Check dated 2026-08-10T13:24:02.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.4, indicating a software update to the study page. The update does not modify the study content or visible information.
    Difference
    0.0%
    Check dated 2026-07-27T06:33:02.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Expanded the study's recruitment footprint by adding 24 sites across Italy, Greece, Czechia, and other countries, reflecting a multi-site design. The sponsor organization name was updated from Stichting European Myeloma Network to European Myeloma Network B.V., with the related location listings adjusted accordingly.
    Difference
    3%
    Check dated 2026-07-20T02:07:56.000Z thumbnail image

Stay in the know with updates to Dara-VCd vs VTd, Maintenance with IXA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.